Trial Profile
Proposal for the development of a well defined database for patients with oral bisphosphonate-related osteonecrosis of the jaws (BON).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary) ; Bisphosphonates (Primary)
- Indications Osteoporosis
- Focus Adverse reactions
- 27 Feb 2012 Actual patient number (35) added as reported by ClinicalTrials.gov.
- 27 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jan 2010 Planned end date changed from 1 Dec 2009 to 1 Mar 2010 as reported by ClinicalTrials.gov.